• Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
PsyNews.com
  • Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Home Featured Page 83

Featured

Latest
  • Latest
  • Featured posts
  • Most popular
  • 7 days popular
  • By review score
  • Random

Year in Review: Psychedelics in 2025 (Video)

The Psychedelic News Feed: December 15 – 21, 2025

Tricia Eastman: Seeding Consciousness, Ancestral Wisdom, and Psychedelic Initiation

Psilocybe Mushroom Pickers in Britain

Pα+ Psychedelic Bulletin #216: Australia’s Psychedelics-for-Veterans Funding; New Mexico Targets 2026 Medical Psilocybin Launch; Radial Scores $50M; Otsuka’s “Novel Serotonergic Agonists”; Psilocybin Accelerates Brain...

Psyence Appoints Intellectual Property Expert to Its Board of Directors

Numinus to Present at the Small Cap Growth Virtual Investor Conference...

Bright Minds Announces Effective Date of Share Consolidation

Revive Therapeutics Announces Results of Phase 3 Clinical Study for Bucillamine...

Psychedelic Research Bulletin: June 2023

American Medical Association Releases Language of First New Current Procedural Terminology...

PT421 – The Impact of the Therapeutic Alliance on the Psychedelic...

FILAMENT HEALTH TO SUPPLY PSILOCYBIN FOR RECIPIENTS OF THE CANADIAN INSTITUTES...

COMPASS Pathways Secures Term Loan Facility for Up to $50 Million...

Small Pharma Announces SPL028 R&D Strategy Update

1...828384...304Page 83 of 304

EDITOR PICKS

Year in Review: Psychedelics in 2025 (Video)

The Psychedelic News Feed: December 15 – 21, 2025

Tricia Eastman: Seeding Consciousness, Ancestral Wisdom, and Psychedelic Initiation

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY

    ABOUT US
    PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.
    FOLLOW US
    ©